Alert: EMEA Reconsidering Acomplia Marketing 

The European Medicines Agency (EMEA) has recommended that marketing of Acomplia (rimonabant) be suspended in the Europe Union due to concerns about psychiatric side effects. The EMEA's Committee for Medicinal Products...

The Food and Drug Administration issued a MedWatch alert this week urging physicians to discontinue the use of Byetta in patients suspected to be suffering from pancreatitis. Since October 2007, the FDA has received reports of six cases...

ICD-10 OMB Sign-On Letter 

This letter expresses our deep concerns regarding the U.S. Department of Health and Human Services' (HHS) plan to mandate the rapid implementation of the International Statistical Classification...

GAO Imaging Report Sign-On Letter

The undersigned organizations are writing to provide our views on the findings in the Government Accountability Office (GAO) report, "Medicare Part B Imaging Services -- Rapid Spending Growth..."

Earlier this week, the U.S. Food and Drug Administration announced that EMD Serono has made a business decision to discontinue the manufacture of Geref Diagnostic...